Verrica Pharmaceuticals (VRCA) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Verrica Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 5 insiders bought $18.2M and 0 sold $0 of VRCA stock on the open market, including a cluster buy that began Aug 14, 2026.
Get emailed when insiders cluster-buy stocks like VRCA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
VRCA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $211K | 6 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $18.0M | 6 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 5 Verrica Pharmaceuticals Inc. insiders reported open-market purchases totaling $18.2M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Aug 14, 2026, when 4 insiders bought a combined $201K. Among insiders with enough purchase history to measure, Paul B Manning (Director) has the highest Insider Score at 86.
VRCA stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Earnings release
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 18SEC | Jayson RiegerCEO, President | Buy | 20,000202,593 held (+11%) | $5.06 | $101K | -18.8% | — |
| Aug 18SEC | David ZawitzCOO | Buy | 6,00027,000 held (+29%) | $4.98 | $30K | -17.5% | — |
| Aug 18SEC | John J. KirbyCFO | Buy | 5,00023,962 held (+26%) | $4.93 | $25K | -16.6% | — |
| Aug 18SEC | Jayson RiegerCEO, President | Buy | 5,000207,593 held (+2%) | $4.91 | $25K | -16.3% | — |
| Aug 18SEC | Noah L. RosenbergCmo | Buy | 4,2006,557 held (+178%) | $4.91 | $21K | -16.3% | — |
| Aug 18SEC | Noah L. RosenbergCmo | Buy | 2,0308,587 held (+31%) | $4.92 | $10K | -16.5% | — |
| Nov 25SEC | Paul B ManningDirector | Buy | 2,750,7623,348,372 held (+460%) | $4.24 | $11.7M | -3.1% | 86 |
| Nov 25SEC | Paul B ManningDirector | Buy | 1,375,3803,958,189 held (+53%) | $4.24 | $5.8M | -3.1% | 86 |
| Nov 25SEC | Jayson RiegerCEO, President | Buy | 94,311182,593 held (+107%) | $4.24 | $400K | -3.1% | — |
| Nov 25SEC | David ZawitzCOO | Buy | 10,00021,000 held (+91%) | $4.24 | $42K | -3.1% | — |
| Nov 25SEC | John J. KirbyCFO | Buy | 3,5368,962 held (+65%) | $4.24 | $15K | -3.1% | — |
| Nov 25SEC | Noah L. RosenbergCmo | Buy | 2,357new position | $4.24 | $10K | -3.1% | — |
Insiders at Verrica Pharmaceuticals Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Paul B ManningDirector | $17.5M | — | Nov 25, 2025 | 86 |
| Jayson RiegerCEO, President | $526K | — | Aug 18, 2026 | — |
| David ZawitzCOO | $72K | — | Aug 18, 2026 | — |
| Noah L. RosenbergCmo | $41K | — | Aug 18, 2026 | — |
| John J. KirbyCFO | $40K | — | Aug 18, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
VRCA stock: common questions
Are Verrica Pharmaceuticals Inc. insiders buying VRCA stock?
In the past 12 months, 5 insiders reported open-market purchases of VRCA worth $18.2M. The latest was CEO, President Jayson Rieger bought $101K of VRCA at $5.06.
Are Verrica Pharmaceuticals Inc. insiders selling VRCA stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is VRCA's 52-week range?
Over the past year VRCA has traded between $3.28 and $9.10. It last closed at $4.11 on Oct 9, 2026.